Faron Pharmaceuticals OY (FARN) NPV
0.50p
(0.94%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.50p
(0.94%)
0.50p
(0.94%)
53.00p
54.70p
890.00p
£15.80 million
53.00p
53.00p
51.00p
n/a
0.00p (0.00%) Previous:
0.00p
22,623
n/a
500
Performance
Not available for this stock.
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Open an easy to manage, low cost dealing account in less than 5 minutes
Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.
More about the Fund and Share AccountImportant Documents
There are no documents available for this stock.
Broker forecasts
Broker recommendations for this stock are not available.
-
Faron Pharmaceuticals pins some hope to YODA trial
19 December 2018 11:07
-
Dosing begins in Faron's study of 'Clevegen' drug
14 December 2018 15:57
-
Traumakine treatment optimal for particular subgroup, Faron finds
5 December 2018 10:13
-
Traumakine update - YODA results
19 December 2018 07:00
-
First patient dosed in phase I/II MATINS study
14 December 2018 11:20
-
Holding(s) in Company
11 December 2018 16:26
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.